Systemic immune-inflammatory biomarkers (SII, NLR, PLR, and LMR) and its relation with the risk of non-alcoholic fatty liver disease (NAFLD)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202602534690395

Enrollment

230

Registered

2026-02-16

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System

Interventions

systemic immune inflammatory biomarkers

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Adults aged = 18 :65years. • Both sexes. • NAFLD individuals.

Exclusion criteria

Exclusion criteria: • Chronic viral hepatitis (HBV or HCV). • Malignancy or autoimmune disease. • Alcohol consumption. • Advanced liver cirrhosis or other chronic liver disorders • Recent infection or inflammatory disease. • Receiving immunosuppressive therapy or steroids.

Design outcomes

Primary

Measure	Time frame
Systemic Immune-Inflammation Index SII = (Platelets × Neutrophils) / Lymphocytes	—

Secondary

Measure	Time frame
Platelet-to-Lymphocyte Ratio PLR = Platelets / Lymphocytes	—

Countries

Egypt

Contacts

Public ContactMoayed Hatem Fathy

Assiut university

Moaied.15235823@med.aun.edu.eg+201103763126

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026